Red Cell Distribution Width,,NT-proBNP and cTnT in Acute Myocardial Infraction Patient

Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05595278
Collaborator
(none)
30
1
8
3.8

Study Details

Study Description

Brief Summary

the study is to investigate the relationship of several parameters of complete blood count (CBC) including RDW with N-terminal pro-B-type natriuretic peptide (NT-proBNP) and cardiac troponin T (cTnT) in a cohort of acute myocardial infarction (AMI) patients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: (CBC) ,(NT-proBNP) ,(cTnT)

Detailed Description

Patients and methods:
  • Type of study: Observational prospective study

  • Place of study: Sohag cardiology and gastroenterology center, department of cardiology and cardiac care unit.

  • Ethical considerations: This research will be revised by the Scientific Ethical Committee of Sohag University Hospital. Consents will be taken from all patients.

  • Study Methods:

  • A prospective study on 30 patients diagnosed as acute myocardial infarction on which measurement of CBC, serum NT-proBNP, and cTnT levels will be performed at the time of admission and by the time of discharge.

  • All patients included in the study will be subjected to:

  1. Full history:

  2. Personal history: e.g. age, sex and smoking.

  3. Family history of cardiac diseases

  4. Medical history of: Hypertension, Ischemic heart disease, prior coronary artery bypass grafting, Prior Percutaneous coronary intervention, Prior Stroke, Prior Atrial fibrillation, therapeutic history

  5. Detailed clinical examination

  6. Electrocardiogram

  7. Laboratory investigation:

  8. Routine investigation in the form of CBC including RDW

  9. Specific investigation which include NT-proBNP and cTnT

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Detrmination of the Relationship Between Red Cell Distribution Width ,NT-proBNP and cTnT in Acute Myocardial Infraction Patients
Anticipated Study Start Date :
Nov 13, 2022
Anticipated Primary Completion Date :
Jun 13, 2023
Anticipated Study Completion Date :
Jul 13, 2023

Outcome Measures

Primary Outcome Measures

  1. (CBC) [6 months]

    measurement of CBC will be performed at the time of admission and by the time of discharge.

  2. (NT-proBNP [6 months]

    measurement of serum NT-proBNP levels will be performed at the time of admission and by the time of discharge.

  3. (cTnT) [6 months]

    measurement of cTnT levels will be performed at the time of admission and by the time of discharge

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients diagnosed as acute myocardial infarction and admitted to department of cardiology and cardiac care unit at Sohag cardiology and gastroenterology center according to inclusion and exclution criteria
Exclusion Criteria:
Patient with:
  • Decompensated heart failure

  • Pulmonary hypertention

  • Acute pulmonary embolism

  • Septic shock

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag University Hospital Sohag Egypt

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Hemat Kamel Maarouf, Resident doctor at clinical and chemical pathology department, Sohag University
ClinicalTrials.gov Identifier:
NCT05595278
Other Study ID Numbers:
  • Soh-Med-2210-05
First Posted:
Oct 26, 2022
Last Update Posted:
Nov 15, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2022